What is Genetics Center?
Established in 1986, Genetics Center operates as a premier laboratory and clinical services provider with a specialized focus on human genetics. The company provides a comprehensive suite of diagnostic solutions, including prenatal diagnosis, cancer genetics, and molecular diagnostics. By utilizing advanced methodologies such as next-generation sequencing and cytogenetic analysis, the firm serves a critical role for patients and referring physicians who require high-fidelity genetic insights. Their long-standing commitment to excellence in laboratory testing has solidified their reputation as a trusted partner in the medical community, bridging the gap between complex genomic data and actionable clinical outcomes.
How much funding has Genetics Center raised?
Genetics Center has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Genetics Center
PPP
Public-Private Partnership
What's next for Genetics Center?
With the successful completion of this late-stage financing, Genetics Center is poised to accelerate its strategic growth initiatives. The company is expected to prioritize the integration of cutting-edge sequencing technologies to further reduce turnaround times and improve diagnostic accuracy. Furthermore, the capital will likely support the expansion of their clinical footprint, allowing for broader access to their specialized testing services. As the healthcare industry continues to shift toward personalized medicine, Genetics Center is strategically aligned to capitalize on the rising adoption of genomic-based diagnostics, ensuring they remain at the forefront of clinical innovation and patient-centric care.
See full Genetics Center company page
